Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Claimed Company
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions read more
Excellent medical, dental, and vision coverage.
What makes you most happy at work?
Celebrating success achieved as a team.
What are some of the best things about your team?
We all work hard together to meet deadlines and help patients.
What do you like best about the leadership team?
The leadership team is connected to everyone, not isolated in a board room.
Other Employee Reviews for Karyopharm Therapeutics
×